Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion type Assertion NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_head.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion description "[Furthermore, NEFL physically associated with tuberous sclerosis complex 1 (TSC1), a known inhibitor of the mTOR pathway, and NEFL downregulation led to functional activation of mTOR pathway and consequentially conferred cisplatin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_provenance.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion evidence source_evidence_literature NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_provenance.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion SIO_000772 22246235 NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_provenance.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion wasDerivedFrom befree-20140225 NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_provenance.
- NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_assertion wasGeneratedBy ECO_0000203 NP550131.RAES9LMhmuCyDNPiIwhPIp04GseU-8_to5UzSw_R2TtHI130_provenance.